MYNZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics...

Stats
Today's Volume	64 806.00
Average Volume	82 185.00
Market Cap	15.05M
EPS	$0 ( 2024-04-08 )
Next earnings date	( $-0.310 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.550
ATR14	$0.00900 (1.00%)

Volume Correlation

Long: 0.08 (neutral)

Short: -0.33 (neutral)

Signal:(61.275) Neutral

Mainz Biomed B.V. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mainz Biomed B.V. Correlation - Currency/Commodity

0.30
( neutral )

0.39
( neutral )

0.00
( neutral )

-0.30
( neutral )

Mainz Biomed B.V. Financials

Annual	2023
Revenue:	$895 479
Gross Profit:	$509 659 (56.91 %)
EPS:	$-1.620

Q3	2023
Revenue:	$181 669
Gross Profit:	$87 186.00 (47.99 %)
EPS:	$-0.390

Q2	2023
Revenue:	$248 945
Gross Profit:	$148 798 (59.77 %)
EPS:	$-0.550

Q1	2023
Revenue:	$250 104
Gross Profit:	$138 941 (55.55 %)
EPS:	$-0.450

Financial Reports:

No articles found.

Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.